
AnPac Bio-Medical Science Co., Ltd. ANPC
Annual report 2022
added 12-27-2025
AnPac Bio-Medical Science Co., Ltd. Depreciation & Amortization 2011-2026 | ANPC
Annual Depreciation & Amortization AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.7 M | 3.91 M | 3.1 M | 2.66 M | 3.14 M | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.7 M | 2.66 M | 3.5 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
Aptorum Group Limited
APM
|
1.13 M | $ 0.88 | - | $ 6.47 M | ||
|
Aquestive Therapeutics
AQST
|
548 K | $ 4.12 | 0.37 % | $ 441 M | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
24.9 M | $ 9.7 | 1.09 % | $ 627 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 21.83 | -2.76 % | $ 3.62 B | ||
|
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
681 K | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
3.14 M | - | - | $ 3.74 B | ||
|
Cerus Corporation
CERS
|
1.43 M | $ 2.91 | 43.35 % | $ 555 M | ||
|
Caladrius Biosciences
CLBS
|
174 K | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
199 K | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.1 M | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.63 M | - | - | $ 2.02 B | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | ||
|
Editas Medicine
EDIT
|
5.28 M | $ 2.9 | -3.33 % | $ 257 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.04 | -4.7 % | $ 5 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
275 K | - | -9.21 % | $ 2.55 M | ||
|
Edesa Biotech
EDSA
|
186 K | $ 18.7 | 2.33 % | $ 59.8 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
77 K | - | -5.68 % | $ 8.28 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M |